title: Additional rearrangements affecting the derivative chromosome 9 involved in the standard Philadelphia translocation after imatinib therapy in a patient with chronic myeloid leukemia.
authors.forename: Huan-Ping
authors.initials: HP
authors.lastname: Wang
authors.forename: Zhi-Mei
authors.initials: ZM
authors.lastname: Chen
authors.forename: Ji-Yu
authors.initials: JY
authors.lastname: Lou
authors.forename: Huan
authors.initials: H
authors.lastname: Xu
authors.forename: Yun-Biao
authors.initials: YB
authors.lastname: Yu
authors.forename: Jie
authors.initials: J
authors.lastname: Jin
mesh_terms: D000328:Adult; D001549:Benzamides; D002869:Chromosome Aberrations; D002891:Chromosomes, Human, Pair 21; D002899:Chromosomes, Human, Pair 9; D006801:Humans; D000068877:Imatinib Mesylate; D017404:In Situ Hybridization, Fluorescence; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D014178:Translocation, Genetic
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate